Pfizer to absorb Mylan, creating generic giant
Pfizer Inc. shareholders will own 57% of the combined new company and Mylan shareholders will own 43%.
Pfizer Inc. shareholders will own 57% of the combined new company and Mylan shareholders will own 43%.